Cancer cells can promote the actin skeleton changes of CTL, downregulate the RAS homologs Rho and Rac1, and promote the living star of Cdc42, resulting in negative regulation of integrin in CTL and subsequent mucosal and motor defects (45–47). The gene discussed is RHO; the disease is cancer.